Judit Axmann

958 citations
11 papers · 610 · 1 hit paper · h-index 6

Impact in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Medical Imaging and Pathology Studies
    • Occupational and environmental lung diseases
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Respiratory and Cough-Related Research
    • Sarcoidosis and Beryllium Toxicity Research

Papers in

Judit Axmann

11 papers receiving 603 citations

Judit Axmann's Hit Papers

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial 2019 · 401 citations
4010+2+4Years since publication100200300400

Peers

Judit Axmann
Comparison fields: 5 of 43
  • Pulmonary and Respiratory Medicine 538
  • Physiology 147
  • Pathology and Forensic Medicine 80
  • Rheumatology 34
  • Epidemiology 50
Replace Cathryn Lee with:
Cathryn Lee United States
N. Sathi United Kingdom
Julia Wälscher Germany
Cathryn T. Lee United States
S. Arthanari United Kingdom
John Hutchinson United Kingdom
Yongfeng Zhang China
Koushi Yokomura Japan
Akihiko Sokai Japan
Ai Cui China
Judit Axmann relative to Cathryn Lee United States Cathryn Lee's profile →
Citations per field
00.5×1.5×
Cathryn Lee · 1×
Citations per year

Countries citing papers authored by Judit Axmann

Since Specialization
Citations

This map shows the geographic impact of Judit Axmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Axmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Axmann more than expected).

Fields of papers citing papers by Judit Axmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Axmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Axmann. The network helps show where Judit Axmann may publish in the future.

Co-authors

The 23 scholars most cited alongside Judit Axmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judit Axmann Line = papers co-authored together Judit Axmann links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
2019401
2 201773
3 201857
4 201843
5 202217
6 20217
7 20223
8 20203
9 20163
10 20192
11 20171

About Judit Axmann

Judit Axmann is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Infectious Diseases, Organic Chemistry and Surgery, having authored 11 papers that have together received 610 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers) and Respiratory and Cough-Related Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (538 citations), Physiology (147 citations), Pathology and Forensic Medicine (80 citations), Rheumatology (34 citations) and Epidemiology (50 citations). Judit Axmann has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include Toby M. Maher, María Molina‐Molina, Michael Kreuter, Klaus-Uwe Kirchgaessler, Vincent Cottin, Tamera J. Corte, Aryeh Fischer, David J. Lederer, Frank Gilberg and Katerina Samara. Their work appears in journals such as BMC Pulmonary Medicine, Respiration, Advances in Therapy, Thorax and The Lancet Respiratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact